1. Home
  2. CSGP vs ARGX Comparison

CSGP vs ARGX Comparison

Compare CSGP & ARGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CSGP
  • ARGX
  • Stock Information
  • Founded
  • CSGP 1987
  • ARGX 2008
  • Country
  • CSGP United States
  • ARGX Netherlands
  • Employees
  • CSGP N/A
  • ARGX N/A
  • Industry
  • CSGP Business Services
  • ARGX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • CSGP Consumer Discretionary
  • ARGX Health Care
  • Exchange
  • CSGP Nasdaq
  • ARGX Nasdaq
  • Market Cap
  • CSGP 31.8B
  • ARGX 40.4B
  • IPO Year
  • CSGP 1998
  • ARGX 2017
  • Fundamental
  • Price
  • CSGP $79.91
  • ARGX $571.00
  • Analyst Decision
  • CSGP Buy
  • ARGX Strong Buy
  • Analyst Count
  • CSGP 15
  • ARGX 20
  • Target Price
  • CSGP $87.87
  • ARGX $682.00
  • AVG Volume (30 Days)
  • CSGP 4.4M
  • ARGX 271.9K
  • Earning Date
  • CSGP 04-22-2025
  • ARGX 05-08-2025
  • Dividend Yield
  • CSGP N/A
  • ARGX N/A
  • EPS Growth
  • CSGP N/A
  • ARGX N/A
  • EPS
  • CSGP 0.34
  • ARGX 12.78
  • Revenue
  • CSGP $2,736,200,000.00
  • ARGX $2,252,039,000.00
  • Revenue This Year
  • CSGP $12.60
  • ARGX $57.59
  • Revenue Next Year
  • CSGP $13.05
  • ARGX $31.90
  • P/E Ratio
  • CSGP $234.44
  • ARGX $43.98
  • Revenue Growth
  • CSGP 11.45
  • ARGX 77.52
  • 52 Week Low
  • CSGP $68.26
  • ARGX $349.86
  • 52 Week High
  • CSGP $100.38
  • ARGX $678.21
  • Technical
  • Relative Strength Index (RSI)
  • CSGP 61.09
  • ARGX 26.36
  • Support Level
  • CSGP $75.79
  • ARGX $618.21
  • Resistance Level
  • CSGP $77.35
  • ARGX $642.24
  • Average True Range (ATR)
  • CSGP 2.64
  • ARGX 15.96
  • MACD
  • CSGP 0.25
  • ARGX -5.58
  • Stochastic Oscillator
  • CSGP 70.37
  • ARGX 4.08

About CSGP CoStar Group Inc.

CoStar Group is a leading provider of commercial real estate data and marketplace listing platforms. Its data offering contains in-depth analytical information on over 5 million commercial real estate properties related to various subsectors including office, retail, hotels, multifamily, healthcare, industrial, self-storage, and data centers. It operates many flagship brands such as CoStar Suite, LoopNet, Apartments.com, BizBuySell, and Lands of America, with more than 80% of its revenue classified as subscription-based. The company recently expanded its presence in Canada, the United Kingdom, Spain, and France.

About ARGX argenx SE

Argenx is a Dutch company focused on using its antibody engineering technology to treat rare autoimmune diseases. Vyvgart (efgartigimod) was initially approved in the US in December 2021 as a treatment for generalized myasthenia gravis, followed by approvals in Europe and Japan in 2022.

Share on Social Networks: